<DOC>
	<DOCNO>NCT00111982</DOCNO>
	<brief_summary>The purpose study determine long-term efficacy continuous IPu liatermin infusion administer concomitant standard anti-Parkinsonian therapy .</brief_summary>
	<brief_title>Trial Extended Treatment With Liatermin ( r-metHuGDNF ) Administered Continuous Intraputaminal ( IPu ) Infusion Subjects With Idiopathic Parkinson 's Disease Who Have Completed Previous Trial Liatermin</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Completion 20020168 protocol</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>bilateral , idiopathic Parkinson 's Disease</keyword>
</DOC>